Real-world efficacy and safety of tofacitinib on the progression of skin sclerosis in patients with systemic sclerosis: An analysis of national multicenter data from the Chinese Rheumatism Data Center (CRDC)-Supplementary materials

Description

This document provides the supplementary materials for the article entitled “Real-world efficacy and safety of tofacitinib on the progression of skin sclerosis in patients with systemic sclerosis: An analysis of national multicenter data from the Chinese Rheumatism Data Center (CRDC)”. The supplementary materials include multiple figures and tables that support the findings of the main manuscript.

Institutions

• Chinese Academy of Medical Sciences & Peking Union Medical College

  Beijing, Beijing

Categories

Licence